Search
for
Sort by
Research 91–120 of 1000+
- Effect of Particle Size on Physical Properties, Dissolution, In Vitro Antioxidant Activity, and In Vivo Hepatoprotective Properties of Tetrastigma hemsleyanum Diels et Gilg Powders
- Celiac Disease: Beyond Diet and Food Awareness
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- Ectopic olfactory receptors in human: New therapeutic possibilities
- 66-Year-Old Woman With Painless Vesicular Lesions
- Floral attractants in the black orchid Brasiliorchis schunkeana (Orchidaceae, Maxillariinae): clues for presumed sapromyophily and potential antimicrobial activity
- ‘Follicular Swiss cheese’ pattern–another histopathologic clue to alopecia areata
- Teriflunomide in multiple sclerosis: an update
- Polyphenols rich Hibiscus rosa sinensis Linn. petals modulate diabetic stress signalling pathways in streptozotocin-induced experimental diabetic rats
- Syndromes of Severe Insulin Resistance (SSIRs)
- The eosinophilia-myalgia syndrome
- Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Inhibitory activities of Puerariae Flos against testosterone 5α-reductase and its hair growth promotion activities
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- Dehydrogenase, Cortisol, Dopamine, Zinc, and Vitamin D3 in Iraqi Patients with Polycystic Ovary Syndrome
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Update on the dermatologic use of systemic glucocorticosteroids
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- Adverse effects of voriconazole: Over a decade of use
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Secondary amenorrhea
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Vitamins
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME